These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18271922)

  • 41. [Pathological diagnosis of pediatric Burkitt lymphoma involving bone marrow].
    Sun Q; Chen Z; Liu E; Li Z; Yang Q; Sun F; Ma Y; Zhang H; Zhang P; Ru K
    Zhonghua Bing Li Xue Za Zhi; 2015 Feb; 44(2):95-9. PubMed ID: 25916639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frequent aberrations of chromosome 8 in aggressive B-cell non-Hodgkin lymphoma.
    Pienkowska-Grela B; Witkowska A; Grygalewicz B; Rymkiewicz G; Rygier J; Woroniecka R; Walewski J
    Cancer Genet Cytogenet; 2005 Jan; 156(2):114-21. PubMed ID: 15642390
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular diagnosis of Burkitt's lymphoma.
    Dave SS; Fu K; Wright GW; Lam LT; Kluin P; Boerma EJ; Greiner TC; Weisenburger DD; Rosenwald A; Ott G; Müller-Hermelink HK; Gascoyne RD; Delabie J; Rimsza LM; Braziel RM; Grogan TM; Campo E; Jaffe ES; Dave BJ; Sanger W; Bast M; Vose JM; Armitage JO; Connors JM; Smeland EB; Kvaloy S; Holte H; Fisher RI; Miller TP; Montserrat E; Wilson WH; Bahl M; Zhao H; Yang L; Powell J; Simon R; Chan WC; Staudt LM;
    N Engl J Med; 2006 Jun; 354(23):2431-42. PubMed ID: 16760443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens.
    Carey CD; Gusenleitner D; Chapuy B; Kovach AE; Kluk MJ; Sun HH; Crossland RE; Bacon CM; Rand V; Dal Cin P; Le LP; Neuberg D; Sohani AR; Shipp MA; Monti S; Rodig SJ
    J Mol Diagn; 2015 Jan; 17(1):19-30. PubMed ID: 25468432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An ultrastructural morphometric and immunophenotypic evaluation of Burkitt's and Burkitt's-like lymphomas.
    Payne CM; Grogan TM; Cromey DW; Bjore CG; Kerrigan DP
    Lab Invest; 1987 Aug; 57(2):200-18. PubMed ID: 3497304
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma.
    Kleo K; Dimitrova L; Oker E; Tomaszewski N; Berg E; Taruttis F; Engelmann JC; Schwarzfischer P; Reinders J; Spang R; Gronwald W; Oefner PJ; Hummel M
    BMC Cancer; 2019 Apr; 19(1):322. PubMed ID: 30953469
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The 11q-Gain/Loss Aberration Occurs Recurrently in MYC-Negative Burkitt-like Lymphoma With 11q Aberration, as Well as MYC-Positive Burkitt Lymphoma and MYC-Positive High-Grade B-Cell Lymphoma, NOS.
    Grygalewicz B; Woroniecka R; Rymkiewicz G; Rygier J; Borkowska K; Kotyl A; Blachnio K; Bystydzienski Z; Nowakowska B; Pienkowska-Grela B
    Am J Clin Pathol; 2017 Dec; 149(1):17-28. PubMed ID: 29272887
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas.
    Colomo L; Vazquez I; Papaleo N; Espinet B; Ferrer A; Franco C; Comerma L; Hernandez S; Calvo X; Salar A; Climent F; Mate JL; Forcada P; Mozos A; Nonell L; Martinez A; Carrio A; Costa D; Dlouhy I; Salaverria I; Martin-Subero JI; Lopez-Guillermo A; Valera A; Campo E;
    Am J Surg Pathol; 2017 Jul; 41(7):877-886. PubMed ID: 28288039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
    Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
    Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.
    Dogan A; Bagdi E; Munson P; Isaacson PG
    Am J Surg Pathol; 2000 Jun; 24(6):846-52. PubMed ID: 10843287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnosis of Burkitt lymphoma in due time: a practical approach.
    Cogliatti SB; Novak U; Henz S; Schmid U; Möller P; Barth TF;
    Br J Haematol; 2006 Aug; 134(3):294-301. PubMed ID: 16848772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of timing and precision of histopathological diagnosis on outcomes of patients with Burkitt lymphoma and high-grade B-cell lymphoma.
    Graef CM; Gödel P; Falderbaum P; Balke-Want H; Simon F; Sieg N; Naendrup JH; Neumann MA; Gillessen S; Bröckelmann PJ; Eichenauer DA; Borchmann P; von Tresckow B; Heger JM
    Eur J Haematol; 2022 May; 108(5):403-412. PubMed ID: 35090068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.
    Li S; Lin P; Fayad LE; Lennon PA; Miranda RN; Yin CC; Lin E; Medeiros LJ
    Mod Pathol; 2012 Jan; 25(1):145-56. PubMed ID: 22002575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Burkitt's Lymphoma and B-Cell Lymphoma Unclassifiable With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt's Lymphoma in Patients With HIV: Outcomes in a South African Public Hospital.
    Sissolak G; Seftel M; Uldrick TS; Esterhuizen TM; Mohamed N; Kotze D
    J Glob Oncol; 2017 Jun; 3(3):218-226. PubMed ID: 28717763
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A highly therapy-resistant case of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma showing strong BCL2 staining, otherwise indistinguishable from Burkitt lymphoma.
    Kurita N; Nishikii H; Nakamoto R; Nakamura N; Kondo Y; Okoshi Y; Suzukawa K; Hasegawa Y; Yokoyama Y; Noguchi M; Chiba S
    J Clin Exp Hematop; 2011; 51(1):37-42. PubMed ID: 21628859
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.
    Hummel M; Bentink S; Berger H; Klapper W; Wessendorf S; Barth TF; Bernd HW; Cogliatti SB; Dierlamm J; Feller AC; Hansmann ML; Haralambieva E; Harder L; Hasenclever D; Kühn M; Lenze D; Lichter P; Martin-Subero JI; Möller P; Müller-Hermelink HK; Ott G; Parwaresch RM; Pott C; Rosenwald A; Rosolowski M; Schwaenen C; Stürzenhofecker B; Szczepanowski M; Trautmann H; Wacker HH; Spang R; Loeffler M; Trümper L; Stein H; Siebert R;
    N Engl J Med; 2006 Jun; 354(23):2419-30. PubMed ID: 16760442
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis.
    Kanungo A; Medeiros LJ; Abruzzo LV; Lin P
    Mod Pathol; 2006 Jan; 19(1):25-33. PubMed ID: 16258503
    [TBL] [Abstract][Full Text] [Related]  

  • 58. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
    Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
    J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets.
    Bouska A; Bi C; Lone W; Zhang W; Kedwaii A; Heavican T; Lachel CM; Yu J; Ferro R; Eldorghamy N; Greiner TC; Vose J; Weisenburger DD; Gascoyne RD; Rosenwald A; Ott G; Campo E; Rimsza LM; Jaffe ES; Braziel RM; Siebert R; Miles RR; Dave S; Reddy A; Delabie J; Staudt LM; Song JY; McKeithan TW; Fu K; Green M; Chan WC; Iqbal J
    Blood; 2017 Oct; 130(16):1819-1831. PubMed ID: 28801451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of MYC rearrangement in high grade B cell lymphomas: correlation of MYC immunohistochemistry and FISH analysis.
    Lynnhtun K; Renthawa J; Varikatt W
    Pathology; 2014 Apr; 46(3):211-5. PubMed ID: 24614699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.